- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Stable Growth Stocks
Global Pharmaceuticals & Biotech Stable Growth Stocks
Results
80
80 companies
ALK-Abelló
Market Cap: DKK 51.1b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 230.80
7D
1.5%
1Y
42.5%
Lonza Group
Market Cap: CHF 38.6b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 550.00
7D
2.8%
1Y
4.5%
Eli Lilly
Market Cap: US$963.0b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$1,075.47
7D
1.5%
1Y
35.2%
WuXi XDC Cayman
Market Cap: HK$82.1b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$65.45
7D
-1.5%
1Y
137.6%
Haw Par
Market Cap: S$3.4b
Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.
H02
S$15.33
7D
0.8%
1Y
37.0%
Tonghua Golden-Horse Pharmaceutical Industry CoLtd
Market Cap: CN¥26.3b
Engages in the research, development, manufacture, and sale of pharmaceutical products in China.
000766
CN¥27.26
7D
-1.1%
1Y
89.2%
Haleon
Market Cap: UK£33.0b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.71
7D
-1.7%
1Y
-0.9%
Aurinia Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$16.12
7D
2.8%
1Y
81.9%